Correction: CRLX101, a Nanoparticle–Drug Conjugate Containing Camptothecin, Improves Rectal Cancer Chemoradiotherapy by Inhibiting DNA Repair and HIF1α Free

In this article (Cancer Res 2017;77:112–22), which was published in the January 1, 2017 issue of Cancer Research (1), the same image was inadvertently duplicated in Fig. 3C VEGFA/CPT and Fig. 3D VEGFA/CRLX101. The corrected version of Fig. 3 is below.

The online version of the article has been corrected and no longer matches the print. The authors regret this error.